Clinical Trials Logo

Periodontal Diseases clinical trials

View clinical trials related to Periodontal Diseases.

Filter by:

NCT ID: NCT05756946 Completed - Clinical trials for Periodontal Diseases

Guided Tissue Regeneration With a Periodontal Dressing

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

This randomized, controlled split-mouth study will include 24-40 patients. After GTR, a test and a control side will be selected by means of a computer-generated randomization list. Test sides will receive a periodontal dressing (Coepak") for 14 days and the control sides will receive no periodontal dressing. After 14 days the periodontal dressing will be removed and the pain experience will be recorded. After 6-9 months, the clinical periodontal parameters will be recorded.

NCT ID: NCT05745779 Completed - Clinical trials for Serum HbA1c and Vitamin D, Vitamin B12 Values in Periodontal Diseases

Vitamin D, HbA1c and Vitamin B12 Levels in Patients

Start date: August 11, 2022
Phase:
Study type: Observational

Abstract Aim: to compare the serum vitamin D, HbA1c and vitamin B12 levels in patients with gingivitis and four different periodontitis stages diagnosed according to the 2017 Periodontal Disease Classification. Materials and methods: A total of 606 (378 Female, 228 Male) patients were included in the study. The periodontal status of the patients was diagnosed with gingivitis, stage 1,2,3 and 4 periodontitis groups were formed. HbA1c, vitamin D and vitamin B12 values of the patients were compared and analyzed. Result: Conclusion:

NCT ID: NCT05724251 Completed - Periodontitis Clinical Trials

Effect of Iodine Deficiency on Periodontitis

Start date: October 30, 2021
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to compare urine iodine levels of participants with/without periodontitis. The main question it aims to answer is there a relationship between iodine levels of urine and periodontitis. Participants will give urine samples without any intervention.

NCT ID: NCT05720481 Completed - Clinical trials for Periodontal Diseases

Impact of Periodontal Treatment on Growth Differentiation Factor-15 Levels

Start date: September 20, 2019
Phase: N/A
Study type: Interventional

In light of the controversy that are already approved but that however still exists regarding the efficacy and influence the management of Periodontitis, the aim of this study was to evaluates, at 6-months follow-up, the post-treatment clinical and serum parameters in patients with periodontitis, treated by either Full Mouth Scaling and Root Planing (FM-SRP) treatment versus conventional oral hygiene treatment on serum CRP and Growth differentiation factor-15 levels.

NCT ID: NCT05702892 Completed - Clinical trials for Periodontal Diseases

Evaluation of Bone Metabolism Biomarkers in Periodontal Diseases

Start date: November 5, 2020
Phase: N/A
Study type: Interventional

This study evaluates the levels of biomarkers associated with bone metabolism in patients with different periodontal conditions.

NCT ID: NCT05662475 Completed - Type 2 Diabetes Clinical Trials

Effect of Periodontal Treatment on Visfatin, fetuin-a and Sirtuin 1 of Patients With Periodontitis and Type 2 Diabetes

Start date: November 15, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to determine the concentrations of Visfatin, Fetuin-A and Sirtuin 1 in the gingival crevicular fluid and clinical periodontal parameters in diabetic and systemically healthy individuals and to determine whether non-surgical periodontal treatment had any effect on these biomarkers and periodontal clinical parameters at the end of a 3-month follow-up period. The hypothesis of our study is that gingival crevicular fluid Visfatin, Fetuin-A and Sirtuin 1 concentrations will change with non-surgical periodontal treatment in type 2 diabetic and systemically healthy individuals and that this change will be associated with diabetes and clinical parameters.

NCT ID: NCT05647902 Completed - Clinical trials for Cardiovascular Diseases

Association of Asprosin in Periodontitis and Acute Coronary Syndrome

Start date: January 1, 2022
Phase:
Study type: Observational

Asprosin, a recently discovered glucogenic adipokine, is mainly synthesized by white adipose tissue and released during fasting. Appetite, glucose metabolism, insulin resistance, cell apoptosis, etc. asprosin is associated with diseases such as diabetes, obesity, polycystic ovary syndrome, and cardiovascular diseases. Periodontal tissue may act as a source of endocrine-like inflammatory mediators (such as TNF-α, IL-6 and IL-1) that are important in periodontal inflammation and can affect glucose and lipid metabolism. Production of TNF-α and IL-6 in adipose tissues strengthens the relationship between cardiovascular diseases and periodontitis. Investigators postulated that asprosin may be a candidate for explaining the triangular relationship between cardiovascular and periodontal disease.

NCT ID: NCT05639582 Completed - Clinical trials for Periodontal Diseases

Fractal Analysis Method in Periodontal Disease

Start date: November 5, 2020
Phase: N/A
Study type: Interventional

In this study, the effects of periodontal disease on alveolar bone were investigated using fractal analysis method.

NCT ID: NCT05631600 Completed - Clinical trials for Periodontal Diseases

Manuka Honey as an Adjunct to Non-surgical Periodontal Therapy: Clinical Study

Start date: September 11, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

The goal of this split-mouth clinical trial is to evaluate the effects of Manuka honey applied into periodontal pockets after initial periodontal therapy (NSPT) in the treatment of stage 3 periodontitis. The main question it aims to answer is: • does the adjunct of Manuka honey improve the outcome of the non-surgical periodontal treatment. The intervention in this study was conducted in a split-mouth design, meaning that after completing the NSPT for each subject, Manuka honey was administered as an adjunct to the periodontal treatment in two randomly selected quadrants of the oral cavity around the teeth with a specially designed cannula. This was followed by oral hygiene instructions and training. The home-performed oral hygiene procedures were focused on interdental cleaning using dental floss and toothbrushing with regular fluoride-containing toothpaste. The subjects were also instructed not to use any form of oral antiseptic (e.g., chlorhexidine) or antibiotic during the follow-up period.

NCT ID: NCT05631197 Completed - Dental Caries Clinical Trials

Biomimetic Hydroxyapatite in Pediatric Patients With Asthma and/or Allergic Rhinitis

Start date: March 2, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to compare the incidence of dental caries and the level of demineralization in pediatric patients with asthma and/or allergic rhinitis. Patients will conduct professional oral hygiene at the baseline. The following clinical indexes will be assessed: BEWE Index, Plaque Index, Bleeding Score, Schiff Air Index. Then, patients will be randomly divided into two groups: - Trial group: domiciliary use of Biorepair Total Protection Plus + desensitizing enamel-repair shock treatment twice a day - Control group: domiciliary use of Elmex Caries Protection twice a day The clinical indexes will be assessed again after 1 month (T1), after 3 (T2) and 6 months (T3).